Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Murat Emre And NotAngleterre

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000350 Ebba Lohmann [Turquie] ; Anne-Sophie Coquel [France] ; Aurélie Honoré [France] ; Hakan Gurvit [Turquie] ; Hasmet Hanagasi [Turquie] ; Murat Emre [Turquie] ; Anne L. Leutenegger [France] ; Valérie Drouet [France] ; Mourad Sahbatou [France] ; Gamze Guven [Turquie] ; Nihan Erginel-Unaltuna [Turquie] ; Jean-Francois Deleuze [France] ; Suzanne Lesage [France] ; Alexis Brice [France]A new F-box protein 7 gene mutation causing typical Parkinson's disease.
000631 Murat Emre [Turquie] ; Paul J. Ford ; Ba Ar Bilgiç ; Ergun Y. UçCognitive impairment and dementia in Parkinson's disease: practical issues and management.
000992 C. Warren Olanow [États-Unis] ; Karl Kieburtz ; Olivier Rascol ; Werner Poewe [Autriche] ; Anthony H. Schapira ; Murat Emre ; Helena Nissinen ; Mika Leinonen ; Fabrizio StocchiFactors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
000E11 Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. MolineDonepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
001331 Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
001744 Paolo Barone [Italie] ; Dag Aarsland [Norvège] ; David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Jaime Kulisevsky [Espagne] ; Daniel Weintraub [États-Unis]Cognitive impairment in nondemented Parkinson's disease
001745 Kolbjorn Bronnick [Norvège] ; Murat Emre [Turquie] ; Sibel Tekin [États-Unis] ; Siri B. Haugen [Norvège] ; Dag Aarsland [Norvège]Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease
002108 Dagmar Verbaan [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Murat Emre [Turquie] ; Jacobus J. Van Hilten [Pays-Bas]Psychotic and compulsive symptoms in Parkinson's disease
003354 Werner Poewe [Autriche] ; Erik Wolters [Pays-Bas] ; Murat Emre [Turquie] ; Marco Onofrj [Italie] ; Chuanchieh Hsu [États-Unis] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis]Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study
003457 David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Ian Mckeith [Royaume-Uni] ; Peter Paul De Deyn [Belgique] ; Dag Aarsland [Norvège] ; Chuanchieh Hsu [États-Unis] ; Roger Lane [États-Unis]Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
003537 Guido Alves [Norvège] ; Jan Petter Larsen [Norvège] ; Murat Emre [Turquie] ; Tore Wentzel-Larsen [Norvège] ; Dag Aarsland [Norvège]Changes in motor subtype and risk for incident dementia in Parkinson's disease
003E90 Murat Emre [Turquie]What causes mental dysfunction in Parkinson's disease?
004680 Mahmut Edip Gürol [Turquie] ; Mustafa Ertas [Turquie] ; Hasmet Ayhan Hanagasi [Turquie] ; Hüseyin Alparslan Sahin [Turquie] ; Gençay Gürsoy [Turquie] ; Murat Emre [Turquie]Stiff leg syndrome: Case report
004827 Orhan Barlas [Turquie] ; Ha Met A. Hana As [Turquie] ; Murat Mer [Turquie] ; Hüseyin A. Ahin [Turquie] ; Serra Sencer [Turquie] ; Murat Emre [Turquie]Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism?
004937 Hasmet A. Hana Si [Turquie] ; Gülüstü Kaptano Lu [Turquie] ; Hüseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The use of NMDA antagonist memantine in drug‐resistant dyskinesias resulting from l‐dopa
004B73 Hasmet A. Hanagasi [Turquie] ; Gülüstü Kaptanoglu [Turquie] ; Hüseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024